LIPID-LOWERING TREATMENT IN PATIENTS WITH CKD:THE RESULTS OF SHARP TRIAL ArticleKobalava Zh.D., Villevalde S.V., Milto A.S., Tigay Zh.G.Клиническая фармакология и терапия. Vol. 21. 2012. P.. 12-18
CARDIORENAL SYNDROMES: PATHOGENETIC, CLINICODIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC ASPECTS ArticleMoiseev V.S., Kobalava Zh.D.Terapevticheskii Arkhiv. Vol. 83. 2011. P.. 5-11
ECHOCARDIOGRAPHIC ASSESSMENT OF MYOCARDIAL FIBROSIS IN YOUNG MEN WITH ARTERIAL HYPERTENSION AND DIFFERENT TYPES OF LEFT VENTRICULAR REMODELING ArticleKobalava Zh.D., Kotovskaya Yu.V., Safarova A.F., Moiseev V.S.Kardiologiia. Vol. 51. 2011. P.. 34-39
EFFICACY OF IVABRADIN IN COMBINED TREATMENT OF PATIENTS WITH POSTINFARCTION SYSTOLIC CHRONIC CARDIAC FAILURE ArticlePotapenko A.V., Abdulazizov O.Sh., Dyachuk L.I., Kiyakbaev G.K., Kobalava Zh.D., Moiseev V.S.Terapevticheskii Arkhiv. Vol. 83. 2011. P.. 19-26
STATINS IN PRIMARY PROPHYLAXIS OF CARDIOVASCULAR DISEASES ArticleKobalava G.D.Terapevticheskii Arkhiv. Vol. 83. 2011. P.. 70-75
VENOUS THROMBOEMBOLISM IN PATIENTS WITH HEART FAILURE ArticleAverkov O.V., Shevchenko I.V., Mirilashvili T.Sh., Kobalava Zh.D.Cardiovascular Therapy and Prevention. Vol. 10. 2011. P.. 101-106
A PHASE I SAFETY AND PHARMACOKINETIC STUDY OF EVEROLIMUS, AN ORAL MTOR INHIBITOR, IN SUBJECTS WITH IMPAIRED HEPATIC FUNCTION ArticlePeveling-Oberhag J., Zeuzem S., Yong W.P., Kunz T., Paquet T., Bouillaud E., Urva S., Anak O., Sellami D., Kobalava Z.EUROPEAN JOURNAL OF CANCER. Vol. 47. 2011.
MICROALBUMINURIA IS THE MOST INTEGRATED SIGN OF SUBCLINICAL ORGAN DAMAGE IN UNCOMPLICATED HYPERTENSIVE PATIENTS ArticleVillevalde S., Milto A., Moiseev V., Kobalava Z.European Heart Journal. Vol. 32. 2011. P.. 14-14
PREVALENCE AND DETERMINANTS OF MASKED INEFFICACY OF ANTIHYPERTENSIVE TREATMENT ArticleVillevalde S., Kotovskaya Y., Mirilashvili T., Kobalava Z.European Heart Journal. Vol. 32. 2011. P.. 427-427
THE EFFICACY OF IVABRADIN IN PATIENTS HOSPITALIZED WITH ACUTE CORONARY SYNDROME ArticleMoiseev V., Dyatchuk L., Potapenko A., Abdulazizov A., Kiyakbaev G., Kobalava Z.H.European Heart Journal. Vol. 32. 2011. P.. 731-732
NATRIURETIC PEPTIDE INHIBITION IN THE PRESENCE OF ANGIOTENSIN RECEPTOR BLOCKADE FOLLOWING SHORT-TERM TREATMENT WITH LCZ696 IN HEART FAILURE PATIENTS: EFFECT ON ANP, BNP, NT-PROBNP AND CGMP ArticleKobalava Z., Averkov O., Meray I., Alexandriya L., Moiseev V., Albrecht D., Feng A., Chandra P., Jordaan P.J.European Heart Journal. Vol. 32. 2011. P.. 784-785
MICROALBUMINURIA IN RISK STRATIFICATION OF NON-DIABETIC HYPERTESIVE PATIENTS ArticleVillevalde S., Tuykhmenev E., Klimenko A., Pigareva Y., Kobalava Z.Вестник Российского университета дружбы народов. Серия: Медицина. 2011. P.. 57-61
CARDIOVASCULAR RISK FACTORS AND DIABETIC FOOT SYNDROME IN SOUTH INDIAN DIABETIC POPULATION ArticleRENNIS M.M., SHAVAROVA E.K., KOBALAVA ZH.D.Вестник Российского университета дружбы народов. Серия: Медицина. 2011. P.. 11-16
CARDIORENAL SYNDROMES: CLASSIFICATION, PATHOPHYSIOLOGICAL MECHANISMS, DIAGNOSTIC PRINCIPLES ArticleKobalava Zh., Villevalde S., Efremovtseva M., Tyukhmenev E., Klimenko A.Врач. 2011. P.. 2-6
ACHIEVEMENTS AND PROBLEMS OF MODERN TRIALS OF ANTIHYPERTENSIVE DRUGS ArticleКобалава Ж.Д., Котовская Ю.В.Kardiologiia. Vol. 51. 2011. P.. 91-99